Onconetix, Inc.

ONCO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Assets
Cash & Equivalents $5.2M $646.5K $4.6M $25.8M $1.9M
Accounts Receivable $296.9K $25.7K $149.7K — —
Inventory $150.0K $64.1K $364.1K — —
Total Current Assets $6.1M $950.3K $5.8M $26.3M $3.1M
Property, Plant & Equipment $37.1K $62.9K $60.7K $14.1K $11.5K
Goodwill $18.5M $27.0M $55.7M — —
Intangible Assets (Excl. Goodwill) — — $25.4M — —
Total Assets $24.9M $28.2M $87.5M $26.3M $3.1M
Liabilities
Accounts Payable $1.8M $3.8M $5.3M $1.5M $582.6K
Total Current Liabilities $9.1M $18.3M $17.2M $3.9M $1.6M
Long-Term Debt — — — — —
Total Liabilities $9.2M $18.6M $21.9M $3.9M $1.6M
Stockholders' Equity
Retained Earnings $-131.2M $-115.7M $-56.8M $-19.4M $-6.0M
Total Stockholders' Equity $15.8M $8.5M $-5.6M $22.4M $1.4M